TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 4 | 2 | 2 | 10 | 98 | 86 | 19 | 36 |
| S | %wins | 25 | 50 | 25 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/4/17 16:24 | 1/3/17 | CLCD | Colucid Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Dallas Matthew D | MA | O | CFO | S | -53 | 36.25 | 9 | -1 | -4 | 40 | D | 326 | 297 | 0 | -1 | -3 | 0 | 0 | -8 | -2 | 30 | |||||
12/1/16 16:43 | 12/1/16 | CLCD | Colucid Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Dallas Matthew D | MA | O | CFO | S | -52 | 35.17 | 9 | -1 | -3 | 42 | D | 532 | 389 | 244 | 2 | 10 | -3 | -2 | 6 | 10 | 1 | |||||
1/20/15 16:32 | 1/16/15 | AVEO | Aveo Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Dallas Matthew D | MA | O | VP,Finan | S | -3 | 0.8170 | 1 | -3 | -17 | 15 | D | -90 | -60 | -33 | -19 | 5 | -10 | -5 | -4 | 7 | 11 | -1 | 118 | 94 | 18 |
1/8/15 16:30 | 1/7/15 | AVEO | Aveo Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Dallas Matthew D | MA | O | VP,Finan | S.d | 0 | 0.7998 | 1 | -1 | -3 | 18 | D | -90 | -53 | -43 | -26 | -8 | 18 | -6 | -5 | 1 | -12 | 8 | 78 | 77 | 19 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |